Table 2.
Diagnostic criteria of COVID-19a
| Classification of the patients | Suspected cases | Clinical confirmed cases (Hubei only) | Pathogenic confirmed cases |
|---|---|---|---|
| Diagnostic basis | Outside Hubei Province: two of the clinical manifestations with at least one of the epidemiological histories, three of the clinical manifestations without epidemiological history | Suspected patient in Hubei Province with CT findings of pneumonia | Suspected or clinically confirmed patients with at least one pathogenic evidence |
| Epidemiological investigation |
1. Travel to or residence in Wuhan in the 14 days prior to symptom onset; 2. Close contactb with SARS-CoV-2 infection (rRT-PCR positive) within 14 days before onset; 3. Exposed to patients from Wuhan and surrounding areas, or from a community with patients who reported fever or respiratory symptoms14 d before onset; 4. Clustering outbreak. |
- | - |
| Clinical manifestations and CT scan |
1. Fever and/or respiratory symptoms; 2. Imaging characteristics of COVID-19(CT: multiple small plaque shadows and interstitial changes in early stage, which are obvious in the peripheral lung, and then develop into multiple ground-glass shadows and infiltration shadows in both lungs, and lung consolidation may occur in severe cases); 3. The total number of white blood cells in the early stage is normal or decreased, and the lymphocyte count is decreased |
- | - |
| Pathogenic evidence | NULL | NULL |
1. Detection of SARS-CoV-2 in respiratory specimens and sera by rRT-PCR assays; 2. By virus DNA sequencing, respiratory or blood samples DNA sequence highly homologous with SARS-CoV-2. |
COVID-19 coronavirus induced disease, SARS-CoV-2 severe acute respiratory syndrome corona virus 2, rRT-PCR real-time reverse transcription-polymerase chain reaction
aThe diagnostic criteria were defined according to Guidance for the Diagnosis and Management for COVID-19 (5th edition) released by National Health Commission of People’s Republic of China in Feb. 4, 2020 [8]
bClose contact is defined as follows:
- Healthcare-associated exposure, including providing direct care for COVID-19 patients, working with healthcare workers infected with novel coronavirus, visiting patients, or staying in the same close environment as a COVID-19 patient
- Working together in close proximity or sharing the same classroom environment with a COVID-19 patient
- Traveling together with a COVID-19 patient in any kind of conveyance
- Living in the same household as a COVID-19 patient